These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34135330)

  • 1. Homing in on genomic instability as a therapeutic target in cancer.
    Bielski CM; Taylor BS
    Nat Commun; 2021 Jun; 12(1):3663. PubMed ID: 34135330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA repair as treatment target.
    Helleday T
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S333-5. PubMed ID: 21944004
    [No Abstract]   [Full Text] [Related]  

  • 3. Universal Genomic Testing Needed to Win the War Against Cancer: Genomics IS the Diagnosis.
    Subbiah V; Kurzrock R
    JAMA Oncol; 2016 Jun; 2(6):719-20. PubMed ID: 27078832
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular mechanism of cell death induced by chemotherapeutic agents].
    Saya H
    Brain Nerve; 2009 Jul; 61(7):843-7. PubMed ID: 19618862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication stress: Driver and therapeutic target in genomically instable cancers.
    Schoonen PM; Guerrero Llobet S; van Vugt MATM
    Adv Protein Chem Struct Biol; 2019; 115():157-201. PubMed ID: 30798931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WEE1 inhibition and genomic instability in cancer.
    Vriend LE; De Witt Hamer PC; Van Noorden CJ; Würdinger T
    Biochim Biophys Acta; 2013 Dec; 1836(2):227-35. PubMed ID: 23727417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-mitotic therapies in cancer.
    Tischer J; Gergely F
    J Cell Biol; 2019 Jan; 218(1):10-11. PubMed ID: 30545842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human RecQL4 helicase plays multifaceted roles in the genomic stability of normal and cancer cells.
    Mo D; Zhao Y; Balajee AS
    Cancer Lett; 2018 Jan; 413():1-10. PubMed ID: 29080750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAMA Oncology Patient Page. The Evolution of a Cancer.
    West HJ; Jin JO
    JAMA Oncol; 2015 Sep; 1(6):850. PubMed ID: 26247697
    [No Abstract]   [Full Text] [Related]  

  • 10. Selected Articles from This Issue.
    Clin Cancer Res; 2020 May; 26(10):2279. PubMed ID: 32414759
    [No Abstract]   [Full Text] [Related]  

  • 11. Giving Up on Precision Oncology? Not So Fast!
    Warner JL
    Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
    [No Abstract]   [Full Text] [Related]  

  • 12. Selected Articles from This Issue.
    Mol Cancer Ther; 2020 Jul; 19(7):1383. PubMed ID: 32616655
    [No Abstract]   [Full Text] [Related]  

  • 13. Rare Mutations in Cancer Drug Resistance and Implications for Therapy.
    Beckman RA; Loeb LA
    Clin Pharmacol Ther; 2020 Sep; 108(3):437-439. PubMed ID: 32648584
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomarkers of Bad Biology: Curse or a Blessing?
    Banerjee S; Sicklick JK
    Ann Surg Oncol; 2019 Feb; 26(2):318-320. PubMed ID: 30539488
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial (Thematic Issue: The Predictive Pathology in the Target Therapy Era).
    Franco R; Cantile M
    Curr Drug Targets; 2017; 18(1):2-3. PubMed ID: 27991404
    [No Abstract]   [Full Text] [Related]  

  • 16. Steps forward for cancer precision medicine.
    Salgado R; Moore H; Martens JWM; Lively T; Malik S; McDermott U; Michiels S; Moscow JA; Tejpar S; McKee T; Lacombe D;
    Nat Rev Drug Discov; 2018 Jan; 17(1):1-2. PubMed ID: 29170471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of kinesins mediates docetaxel resistance in breast cancer cells.
    De S; Cipriano R; Jackson MW; Stark GR
    Cancer Res; 2009 Oct; 69(20):8035-42. PubMed ID: 19789344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Mitosis in Cancer: Emerging Strategies.
    Dominguez-Brauer C; Thu KL; Mason JM; Blaser H; Bray MR; Mak TW
    Mol Cell; 2015 Nov; 60(4):524-36. PubMed ID: 26590712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer and natural selection.
    Fillon M
    J Natl Cancer Inst; 2012 Dec; 104(23):1773-4. PubMed ID: 23213180
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular pathology in therapeutics: where are we now, and where are we going?
    Harrison DJ; Faratian D
    Curr Drug Targets; 2012 Nov; 13(12):1473-4. PubMed ID: 22974390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.